Chitosan-Modified PLGA Nanoparticles for Control-Released Drug Delivery
Poly (lactic-<i>co</i>-glycolic acid) nanoparticles (PLGA NPs) are well recognized as an ideal drug delivery carrier for their biocompatibility and biodegradability. In order to overcome the disadvantage of drug burst release, chitosan (CS) was used to modify the PLGA nanoparticles. In t...
Main Authors: | Boting Lu, Xikun Lv, Yuan Le |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Polymers |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4360/11/2/304 |
Similar Items
-
Gut Organoid as a New Platform to Study Alginate and Chitosan Mediated PLGA Nanoparticles for Drug Delivery
by: Zahra Davoudi, et al.
Published: (2021-05-01) -
Investigation of Effective Parameters on Size of Paclitaxel Loaded PLGA Nanoparticles
by: Fatemeh Madani, et al.
Published: (2018-03-01) -
Enhanced sustained release of furosemide in long circulating chitosan-conjugated PLGA nanoparticles
by: Sapna Kashyap, et al.
Published: (2019-01-01) -
Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis
by: Nusaiba K. Al-Nemrawi, et al.
Published: (2018-03-01) -
Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines
by: Abdullah S. Alshetaili
Published: (2021-09-01)